✦ LIBER ✦

Second line treatment with VM 26, doxorubicin (DXR) and BCNU for relapsed non small cell lung cancer (NSCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Teniposide (VM26) as second-line treatme

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Second line treatment of antiangiogenic

✍ Stani, Simonetta Chiara; Sarmiento, Roberta; Mansueto, Giovanni; Bonginelli, Pao 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Docetaxel and carboplatin combination as

✍ J.W.G. Van Putten; F.M. Wachters; H.J.M. Groen 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Factors influencing response to second-l

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Second-line with vinorelbine in the week

✍ Santoro, A.; Maiorino, L.; Santoro, M. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Second line treatment of non-small cell

✍ Kakolyris, S.; Kourousis, C.; Androulakis, N.; Dimopoulos, M.A.; Papadakis, E.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 210 KB